Tirzepatide is generating buzz in the medical community as a novel therapy for individuals with type 2 diabetes and obesity. With its dual-action mechanism, it is seen as a potential game-changer in managing chronic metabolic conditions. Although semaglutide has previously dominated this space, tirzepatide introduces a more comprehensive approach by targeting two incretin hormones, of... https://biotechlabzsupply.com/